COVID-19 patients who also suffer from high blood pressure are more likely to fall severely ill with the disease, which also leaves them at greater risk of death. Scientists have now found that the immune cells of patients with hypertension are already pre-activated, and that this pre-activation is greatly enhanced under COVID-19.
Click here for original story, An augmented immune response explains the adverse course of COVID-19 in patients with hypertension
Source: ScienceDaily